block.deal — India’s large dealsNSE + BSE · BULK & BLOCK DISCLOSURES

COMPANY PROFILE

Remus Pharmaceuticals L

29 May 2023 – 7 Aug 2026 · NSE

ISIN INE0O5T01011 · REMUS
Reported purchases₹14.23 CrEntire retained profile history
Reported sales₹12.22 CrEntire retained profile history
Disclosed sides95 observed dates
Latest raw close₹932.1NSE · 2026-10-12

Price & disclosure history

Raw, unadjusted closes · purple markers show disclosed dates

NSE unadjusted closing prices · Prices in ₹ per share₹ / share₹500₹600₹700₹800₹900₹1,000₹1,10013 Oct23 Dec9 Mar25 May3 Aug12 Oct2026-08-07: disclosure recordedNSE unadjusted closing prices · Prices in ₹ per share₹ / share₹500₹600₹700₹800₹900₹1,000₹1,10013 Oct11 Feb17 Jun12 Oct2026-08-07: disclosure recorded
242 observed NSE sessions · 2025-10-13 to 2026-10-12 · Missing sessions are not filled.
No corporate-action adjustment or forward filling

Most active reported names

01NEGEN CAPITAL SERVICES PRIVATE LIMITED₹6.10 Cr
02BLUE LOTUS CAPITAL MULTI BAGGER FUND II₹5.30 Cr
03INDIA EMERGING GIANTS FUND LIMITED₹3.26 Cr
04CHHATTISGARH INVESTMENTS LIMITED₹2.88 Cr
05YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .₹2.20 Cr
06MONEYWISE FINANCIAL SERVICES PRIVATE LTD₹1.83 Cr
07JINENDRA G₹1.79 Cr
08JAIN SANJAY POPATLAL₹1.71 Cr
Ranked by value of reported sides · full history

OFFICIAL SHAREHOLDING PATTERNS

Named shareholders

As of 31 Mar 2026 · NSE

8 reporting dates →Ownership changes →SHP coverage →

Filing coverage: 8 collected index entries; 1 unresolved; 0 awaiting collection. Index entries can include revisions and irregular dates. Review coverage →

Only individually named holdings disclosed in available shareholding-pattern filings are shown. Reporting thresholds, missing filings and name differences leave other holdings unobserved. A name match is not verification of a legal identity; absence is not a zero holding. Estimated values use reported shares times an unadjusted official close no later than the reporting date, within seven calendar days; holdings without an eligible close have no value estimate. Scroll horizontally if needed.

REMUS PHARMACEUTICALS LIMITED · Listing ISIN INE0O5T01011

Reported shareholderAs ofSharesCompany stakeEstimated valueCategoryEvidence
Shah Arpit Deepakkumar31 Mar 202620,81,20017.66%₹130.6785 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Roma Vinodbhai Shah31 Mar 202620,27,80017.21%₹127.3256 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Anar Swapnil Shah31 Mar 202620,00,00016.97%₹125.58 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Swapnil Jatinbhai Shah31 Mar 202620,00,00016.97%₹125.58 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
India Emerging Giants Fund Limited31 Mar 20265,73,6004.87%₹36.0163 CrRaw close ₹627.90 · 30 Mar 2026 NSEnamed shareholderOfficial filing ↗NSE · named filing row
Rekha Gunavanth Kumar31 Mar 20261,28,0001.09%₹8.0371 CrRaw close ₹627.90 · 30 Mar 2026 NSEnamed shareholderOfficial filing ↗NSE · named filing row
Hemant Ishwarlal Modi31 Mar 20261,17,6001%₹7.3841 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Renosen Pharmaceuticals Private Limited31 Mar 20261,08,5000.92%₹6.8127 CrRaw close ₹627.90 · 30 Mar 2026 NSEnamed shareholderOfficial filing ↗NSE · named filing row
Mansi Aadarsh Shah31 Mar 20268,0000.07%₹0.5023 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Sonal Hemantbhai Modi31 Mar 20268,0000.07%₹0.5023 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Show 3 more disclosed holdings
Reported shareholderAs ofSharesCompany stakeEstimated valueCategoryEvidence
Vinodkumar Gandalal Shah31 Mar 20266,8000.06%₹0.427 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Alkaben Dipakkumar Shah31 Mar 20262,6000.02%₹0.1633 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
Dhruvalben Vishal Shah31 Mar 20267000.01%₹0.044 CrRaw close ₹627.90 · 30 Mar 2026 NSEpromoterOfficial filing ↗NSE · named filing row
View collection-wide filing coverage · reporting dates can differ across companies

Complete disclosure history

Prices per share · ₹ · Values count reported sides · Scroll horizontally if needed

Date / exchangeCompanyReported participantSideQuantityPriceValueSource
2026-08-07NSEBulkRemus Pharmaceuticals LREMUSBLUE LOTUS CAPITAL MULTI BAGGER FUND IISell63,900₹830.19₹5.30 CrNSE ↗
2023-07-26NSEBulkRemus Pharmaceuticals LREMUSCHHATTISGARH INVESTMENTS LIMITEDSell8,000₹3,599.03₹2.88 CrNSE ↗
2023-06-15NSEBulkRemus Pharmaceuticals LREMUSJINENDRA GBuy7,500₹2,387.92₹1.79 CrNSE ↗
2023-06-01NSEBulkRemus Pharmaceuticals LREMUSINDIA EMERGING GIANTS FUND LIMITEDBuy15,700₹2,079.23₹3.26 CrNSE ↗
2023-06-01NSEBulkRemus Pharmaceuticals LREMUSYUGA STOCKS AND COMMODITIES PRIVATE LIMITED .Sell10,600₹2,079.9₹2.20 CrNSE ↗
2023-05-29NSEBulkRemus Pharmaceuticals LREMUSNEGEN CAPITAL SERVICES PRIVATE LIMITEDBuy34,000₹1,793.9₹6.10 CrNSE ↗
2023-05-29NSEBulkRemus Pharmaceuticals LREMUSMONEYWISE FINANCIAL SERVICES PRIVATE LTDSell10,700₹1,712.85₹1.83 CrNSE ↗
2023-05-29NSEBulkRemus Pharmaceuticals LREMUSJAIN SANJAY POPATLALBuy10,000₹1,711.25₹1.71 CrNSE ↗
2023-05-29NSEBulkRemus Pharmaceuticals LREMUSGPRAKASHCHAND BAID HUFBuy8,000₹1,711.25₹1.37 CrNSE ↗
1–9 of 9 reported sides
1 / 1

Names as reported

REMUS

Identity rules, price gaps and disclosure limitations →

BLOCK.DEAL ARCHIVE

Company profileParticipant profileDaily disclosuresLoading page…

Retrieving the published disclosures.

Loading history…

BLOCK.DEAL ARCHIVE

Deal explorerSource receipt

Retrieving the requested published data.

Loading selection…

Search block.deal

Enter at least two characters. Search names, symbols or ISINs.

Deal company directory →Filing company directory →Participant directory →

About block.deal

India’s block and bulk deal disclosures, brought together from official NSE and BSE reports.

Explore companies, reported participants, daily activity and historical closing prices. Follow each disclosure to its official source, or download the data to explore it yourself.

Coverage & freshness →Official sources & downloads →How the data is interpreted →
Independent data explorer. Not affiliated with NSE or BSE.